| 000 | 01585 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513061339.0 | ||
| 264 | 0 | _c19930809 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(93)91283-r _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchwartz, D H | |
| 245 | 0 | 0 |
_aInduction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJul 1993 |
||
| 300 |
_a69-73 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Antibodies _xblood |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _xadministration & dosage |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aRecombinant Proteins _ximmunology |
| 700 | 1 | _aGorse, G | |
| 700 | 1 | _aClements, M L | |
| 700 | 1 | _aBelshe, R | |
| 700 | 1 | _aIzu, A | |
| 700 | 1 | _aDuliege, A M | |
| 700 | 1 | _aBerman, P | |
| 700 | 1 | _aTwaddell, T | |
| 700 | 1 | _aStablein, D | |
| 700 | 1 | _aSposto, R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 342 _gno. 8863 _gp. 69-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(93)91283-r _zAvailable from publisher's website |
| 999 |
_c8100234 _d8100234 |
||